Previous close | 65.20 |
Open | N/A |
Bid | 57.10 |
Ask | 62.00 |
Strike | 490.00 |
Expiry date | 2024-06-21 |
Day's range | 65.20 - 65.20 |
Contract range | N/A |
Volume | |
Open interest | 2 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.